On Thursday, April 10, 2025 at 4:00 pm during Oral Poster Presentation: Research 3 at NKF SCM25, Dr. Wolfgang Winkelmayer will present a poster titled “Vadadustat for Treatment of Anemia in Older vs ...

PHILADELPHIA and VANCOUVER, British Columbia, March 26, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) ...

The abstracts will be available on the AACR 2025 meeting website. The posters will be available online at Erasca.com/science/presentations following the presentations.

As part of the late-breaking Clinical and Investigative Horizons session on Monday, March 31, data from the first ... 1 Phase 1b/2 clinical trial. A poster presentation on Sunday, March 30 ...

Late Breaker Oral Presentation to Include New Data from Cohort 1 of the MyPEAK™-1 Phase ... and an investigator for the MyPEAK-1 Phase 1b/2 clinical trial. A poster presentation on Sunday, March 30, ...

The oral presentations feature data from the ongoing CONNECT1-EDO51 clinical trial in Duchenne muscular dystrophy (DMD) and from the ongoing FREEDOM-DM1 clinical trial in myotonic dystrophy type 1 ...

As part of the late-breaking Clinical and Investigative Horizons session on Monday, March 31, data from the first cohort of adult ... for the MyPEAK-1 Phase 1b/2 clinical trial. A poster presentation ...

The main risk for the VK2735 clinical program and for Viking as a whole is the very rapid evolution of the obesity market. In the next few quarters, there is a risk of better data from competing ...

including an oral presentation with updated clinical data from the ongoing Phase 2 DENALI clinical trial of azenosertib in patients with platinum-resistant ovarian cancer (PROC), at the Society of ...

This allows marketers and business analysts to quickly build data-backed presentations without manually structuring content or designing slides. “It’s analyzing all the charts in this project ...

The presentations will be available in the Publications section of REGENXBIO's website. ABOUT REGENXBIO Inc. REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives ...

In today’s pharmaphorum podcast, Orr Inbar, co-founder and CEO of QuantHealth, a Tel Aviv-based AI-powered clinical trial design company, discusses how advances in data and AI can help.